Adagio Medical Holdings, Inc Common Stock (NASDAQ:ADGM) — Market Cap & Net Worth
Market Cap & Net Worth: Adagio Medical Holdings, Inc Common Stock (ADGM)
Adagio Medical Holdings, Inc Common Stock (NASDAQ:ADGM) has a market capitalization of $8.40 Million ($8.40 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #27466 globally and #5601 in its home market, demonstrating a -22.86% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Adagio Medical Holdings, Inc Common Stock's stock price $0.38 by its total outstanding shares 22210459 (22.21 Million). Review Adagio Medical Holdings, Inc Common Stoc total liabilities to assess the company's total debt and financial obligations.
Adagio Medical Holdings, Inc Common Stock Market Cap History: 2024 to 2026
Adagio Medical Holdings, Inc Common Stock's market capitalization history from 2024 to 2026. Data shows change from $23.32 Million to $8.40 Million (-78.58% CAGR).
Index Memberships
Adagio Medical Holdings, Inc Common Stock is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.00% | #789 of 976 |
Weight: Adagio Medical Holdings, Inc Common Stock's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Adagio Medical Holdings, Inc Common Stock Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Adagio Medical Holdings, Inc Common Stock's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
86.70x
Adagio Medical Holdings, Inc Common Stock's market cap is 86.70 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $23.32 Million | $269.00K | -$53.76 Million | 86.70x | N/A |
Competitor Companies of ADGM by Market Capitalization
Companies near Adagio Medical Holdings, Inc Common Stock in the global market cap rankings as of August 3, 2026.
Key companies related to Adagio Medical Holdings, Inc Common Stock by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
Adagio Medical Holdings, Inc Common Stock Historical Marketcap From 2024 to 2026
Between 2024 and today, Adagio Medical Holdings, Inc Common Stock's market cap moved from $23.32 Million to $ 8.40 Million, with a yearly change of -78.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $8.40 Million | -63.65% |
| 2025 | $23.10 Million | -0.95% |
| 2024 | $23.32 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Adagio Medical Holdings, Inc Common Stock was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.40 Million USD |
| MoneyControl | $8.40 Million USD |
| MarketWatch | $8.40 Million USD |
| marketcap.company | $8.40 Million USD |
| Reuters | $8.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Adagio Medical Holdings, Inc Common Stock
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLA… Read more